Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A5834
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cancer Biomarkers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Profiling Technology
6.1 Omic Technologies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Imaging Technologies
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Immunoassays
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cytogenetics
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Biomolecule
7.1 Genetic Biomarkers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Protein Biomarkers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Glyco-Biomarkers
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Cancer Type
8.1 Breast Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lung Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Colorectal Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Prostate Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Stomach Cancer
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Application
9.1 Diagnostics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Prognostics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Risk Assessment
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Drug Discovery and Development
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by End User
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Academic and Research Institutions
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Ambulatory Surgical Centers
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Diagnostic Laboratories
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Agilent Technologies Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Becton Dickinson and Company
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 bioMérieux SA
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Danaher Corporation
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 F. Hoffmann-La Roche AG
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 SWOT Analysis
16.3.7 General Electric Company
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Illumina Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Qiagen N.V.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Sino Biological Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Thermo Fisher Scientific Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Cancer Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cancer Biomarkers Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Cancer Biomarkers Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Cancer Biomarkers Market: Breakup by Profiling Technology (in %), 2023
Figure 5: Global: Cancer Biomarkers Market: Breakup by Biomolecule (in %), 2023
Figure 6: Global: Cancer Biomarkers Market: Breakup by Cancer Type (in %), 2023
Figure 7: Global: Cancer Biomarkers Market: Breakup by Application (in %), 2023
Figure 8: Global: Cancer Biomarkers Market: Breakup by End User (in %), 2023
Figure 9: Global: Cancer Biomarkers Market: Breakup by Region (in %), 2023
Figure 10: Global: Cancer Biomarkers (Omic Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Cancer Biomarkers (Omic Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Cancer Biomarkers (Imaging Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Cancer Biomarkers (Imaging Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Cancer Biomarkers (Immunoassays) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Cancer Biomarkers (Immunoassays) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Cancer Biomarkers (Cytogenetics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Cancer Biomarkers (Cytogenetics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Cancer Biomarkers (Genetic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Cancer Biomarkers (Genetic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Cancer Biomarkers (Protein Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Cancer Biomarkers (Protein Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Cancer Biomarkers (Glyco-Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Cancer Biomarkers (Glyco-Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Cancer Biomarkers (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Cancer Biomarkers (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Cancer Biomarkers (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Cancer Biomarkers (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Cancer Biomarkers (Colorectal Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Cancer Biomarkers (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Cancer Biomarkers (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Cancer Biomarkers (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Cancer Biomarkers (Stomach Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Cancer Biomarkers (Stomach Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Cancer Biomarkers (Other Cancer Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Cancer Biomarkers (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Cancer Biomarkers (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Cancer Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Cancer Biomarkers (Prognostics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Cancer Biomarkers (Prognostics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Cancer Biomarkers (Risk Assessment) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Cancer Biomarkers (Risk Assessment) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: Cancer Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: Cancer Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Global: Cancer Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Global: Cancer Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Global: Cancer Biomarkers (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Global: Cancer Biomarkers (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Global: Cancer Biomarkers (Academic and Research Institutions) Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Global: Cancer Biomarkers (Academic and Research Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Global: Cancer Biomarkers (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Global: Cancer Biomarkers (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Global: Cancer Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Global: Cancer Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: North America: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: North America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: United States: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: United States: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Canada: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Canada: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Asia-Pacific: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Asia-Pacific: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: China: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: China: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Japan: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Japan: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: India: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: India: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: South Korea: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: South Korea: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Australia: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Australia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Indonesia: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Indonesia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Europe: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Europe: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Germany: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Germany: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: France: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: France: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: United Kingdom: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: United Kingdom: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Italy: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Italy: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Spain: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: Spain: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Russia: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: Russia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 92: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 93: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 94: Latin America: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 95: Latin America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 96: Brazil: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 97: Brazil: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 98: Mexico: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 99: Mexico: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 100: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 101: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 102: Middle East and Africa: Cancer Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 103: Middle East and Africa: Cancer Biomarkers Market: Breakup by Country (in %), 2023
Figure 104: Middle East and Africa: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 105: Global: Cancer Biomarkers Industry: SWOT Analysis
Figure 106: Global: Cancer Biomarkers Industry: Value Chain Analysis
Figure 107: Global: Cancer Biomarkers Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Cancer Biomarkers Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Cancer Biomarkers Market Forecast: Breakup by Profiling Technology (in Million US$), 2024-2032
Table 3: Global: Cancer Biomarkers Market Forecast: Breakup by Biomolecule (in Million US$), 2024-2032
Table 4: Global: Cancer Biomarkers Market Forecast: Breakup by Cancer Type (in Million US$), 2024-2032
Table 5: Global: Cancer Biomarkers Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 6: Global: Cancer Biomarkers Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 7: Global: Cancer Biomarkers Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Cancer Biomarkers Market: Competitive Structure
Table 9: Global: Cancer Biomarkers Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More